[Therapy of cardiac insufficiency with angiotensin converting enzyme inhibitors. New concepts-new strategies].
The treatment of heart failure has two main objectives: the improvement of the quality of life and the decrease of cardiac mortality. The first has been proved on several open studies and placebo controlled studies, using converting enzyme inhibitors. Mortality of these patients is very high and half is by sudden death. It has been proved, by several important studies, that these drugs can reduce the cardiac mortality probably acting on the arrhythmogenic mechanisms and on the structural deterioration of the heart.
Correia
J F
JF
Serviço de Cardiologia, Hospital de Pulido Valente, Lisboa.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D011788:Quality of Life
D000806:Angiotensin-Converting Enzyme Inhibitors
Terapêutica de insuficiência cardíaca com inibidores da enzima de conversão. Novos conceitos--novas estratégias.